sur Immunic AG
Immunic Engages in Key Conferences this June
Immunic, Inc., a biotechnology firm focused on developing oral therapies for neurological disorders, is set to participate in notable conferences this June. The company's leadership will feature prominently in several events, emphasizing its commitment to advancing treatment solutions.
On June 15-16, CEO Erik Lundgren and President Jason Tardio will engage in a fireside chat during the H.C. Wainwright Neuro Perspectives Expert Summit. Their presentation will be available online, with replays accessible for 90 days.
From June 22-25, Immunic will partake in the BIO International Convention in San Diego, engaging in strategic partnerships.
Additionally, Christian Gege, Ph.D., will present at the EFMC-ACSMEDI Medicinal Chemistry Symposium in Dublin. He will discuss the discovery of IMU-856, focusing on its novel potential for gastrointestinal disease treatment.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Immunic AG